Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Izbicki G, Rudensky B, Na'amad M, et al. Transfusion-related leukocytosis in critically ill patients. Crit Care Med 2004;32:439–442.
-
2. Lin JS, Tzeng CH, Hao TC, et al. Cytokine release in febrile non-haemolytic red cell transfusion reactions. Vox Sang 2002;82:156–160.
-
3. Fenwick JC, Cameron M, Naiman SC, et al. Blood transfusion as a cause of leucocytosis in critically ill patients. Lancet 1994;344:855–856.
-
4. Kristiansson M, Soop M, Saraste L, et al. Post-operative circulating cytokine patterns—the influence of infection. Intensive Care Med 1993;19:395–400.
-
5. McMichael MA, Smith SA, Galligan A, et al. Effect of leukoreduction on transfusion-induced inflammation in dogs. J Vet Intern Med 2010;24:1131–1137.
-
6. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crit Care Med 2004;32:39–52.
-
7. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409–417.
-
8. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499–1507.
-
9. Stack G, Baril L, Napychank P, et al. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995;35:199–203.
-
10. Kristiansson M, Soop M, Saraste L, et al. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996;40:496–501.
-
11. Shanwell A, Kristiansson M, Remberger M, et al. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 1997;37:678–684.
-
12. Weisbach V, Wanke C, Zingsem J, et al. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates. Vox Sang 1999;76:100–106.
-
13. Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003;289:1941–1949.
-
14. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562–568.
-
15. Corsi R, McMichael MA, Smith SA, et al. Cytokine concentration in stored canine erythrocyte concentrates. J Vet Emerg Crit Care (San Antonio) 2014;24:259–263.
-
16. Wardrop KJ, Owen TJ, Meyers KM. Evaluation of an additive solution for preservation of canine red blood cells. J Vet Intern Med 1994;8:253–257.
-
17. Davenport RD, Kunkel SL. Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfus Med Rev 1994;8:157–168.
-
18. Tizard IR. Veterinary immunology. 9th ed. St Louis: Elsevier Saunders, 2013.
-
19. Strieter RM, Kasahara K, Allen RM, et al. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992;141:397–407.
-
20. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1992;307:97–101.
-
21. Van Zee KJ, Fischer E, Hawes AS, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992;148:1746–1752.
-
22. Grunenberg R, Krüger J. Analysis of cytokine profiles of stored CPDA-1 whole blood. Infusionsther Transfusionsmed 1995;22:292–294.
-
23. Kumar A, Lnu S, Malya R, et al. Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma. FASEB J 2003;17:1800–1811.
-
24. Curley GF, Contreras M, Higgins B, et al. Evolution of the inflammatory and fibroproliferative responses during resolution and repair after ventilator-induced lung injury in the rat. Anesthesiology 2011;115:1022–1032.
-
25. Deaton PR, McKellar CT, Culbreth R, et al. Hyperoxia stimulates interleukin-8 release from alveolar macrophages and U937 cells: attenuation by dexamethasone. Am J Physiol 1994;267:L187–L192.
-
26. Horinouchi H, Wang CC, Shepherd KE, et al. TNF alpha gene and protein expression in alveolar macrophages in acute and chronic hyperoxia-induced lung injury. Am J Respir Cell Mol Biol 1996;14:548–555.
-
27. Holowaychuk MK, Leader JL, Monteith G. Risk factors for transfusion-associated complications and nonsurvival in dogs receiving packed red blood cell transfusions: 211 cases (2008–2011). J Am Vet Med Assoc 2014;244:431–437.
-
28. Yazer MH, Podlosky L, Clarke G, et al. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004;44:10–15.
-
29. Ibojie J, Greiss M, Urbaniak SJ. Limited efficacy of universal leucodepletion in reducing the incidence of febrile non-haemolytic reactions in red cell transfusion. Transfus Med 2002;12:387–389.
-
30. King KE, Shirey RS, Thoman SK, et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004;44:25–29.
-
31. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794–797.
-
32. Ezidiegwu CN, Lauenstein KJ, Rosales LG, et al. Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients. Arch Pathol Lab Med 2004;128:991–995.
-
33. Brownlee L, Wardrop KJ, Sellon RK, et al. Use of a prestorage leukoreduction filter effectively removes leukocytes from canine whole blood while preserving red blood cell viability. J Vet Intern Med 2000;14:412–417.
-
34. US FDA. Guidance for industry: pre-storage leukocyte reduction of whole blood and blood components intended for transfusion. Rockville, Md: US Dept Health and Human Services, 2012;1–32.
-
35. Hammer JH, Mynster T, Reimert CM, et al. Reduction of bioactive substances in stored donor blood: prestorage versus bedside leucofiltration. Eur J Haematol 1999;63:29–34.
-
36. McFaul SJ, Corley JB, Mester CW, et al. Packed blood cells stored in AS-5 become proinflammatory during storage. Transfusion 2009;49:1451–1460.
-
37. Herring JM, Smith SA, McMichael MA, et al. Microparticles in stored canine RBC concentrates. Vet Clin Pathol 2013;42:163–169.
-
38. Graf C, Raila J, Schweigert FJ, et al. Effect of leukoreduction treatment on vascular endothelial growth factor concentration in stored canine blood transfusion products. Am J Vet Res 2012;73:2001–2006.
-
39. Paglino JC, Pomper GJ, Fisch GS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44:16–24.
-
40. Blumberg N, Heal JM, Gettings KF, et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010;50:2738–2744.
-
41. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al. Randomised comparison of leucocyte-depleted versus buffy-coat–poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841–845.
-
42. Wu Y, Zou S, Cable R, et al. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction. Transfusion 2010;50:776–786.
-
43. Iazbik MC, O'Donnell M, Marin L, et al. Prevalence of dog erythrocyte antigens in retired racing Greyhounds. Vet Clin Pathol 2010;39:433–435.
-
44. Shiel RE, Brennan SF, O'Rourke LG, et al. Hematologic values in young pretraining healthy Greyhounds. Vet Clin Pathol 2007;36:274–277.
Advertisement
Effect of leukoreduction on concentrations of interleukin-8, interleukin-1β, and tumor necrosis factor-α in canine packed red blood cells during storage
Abstract
OBJECTIVE To measure changes in interleukin-8 (IL-8), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) concentrations in stored canine packed RBCs (PRBCs) over time and assess the effect of leukoreduction on these cytokine concentrations.
ANIMALS 12 anesthetized healthy Greyhounds.
PROCEDURES 1 unit of whole blood from each dog was processed into PRBCs. Half of each PRBCs unit was passed through a leukoreduction filter to produce a leukoreduced unit, and the remaining blood was kept as a nonleukoreduced unit. All units had a CBC performed on day 0 (day of collection) and were stored at 2° to 6°C. Samples were collected from leukoreduced and nonleukoreduced units on days 0, 10, 20, 30, and 37 and centrifuged; the supernatant was stored at −80°C until analysis. Canine TNF-α and IL-8 concentrations were assessed with a multiplexed genomic and proteomic biomarker analyzer, and canine IL-1β concentration was measured by ELISA.
RESULTS Leukocyte counts were decreased by ≥ 99.9% in all leukoreduced units. Median TNF-α and IL-1β concentrations were not significantly different between leukoreduced and nonleukoreduced units and did not change significantly during storage; median IL-8 concentration was significantly higher in nonleukoreduced versus leukoreduced units on all days, and was greater at all time points after ≥ 10 days of storage than on day 0. Median IL-8 concentration in leukoreduced units did not increase during storage.
CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that leukoreduction was effective for the removal of leukocytes from canine PRBCs and prevented significant increases in IL-8 concentration during storage. Further studies are needed to evaluate whether leukoreduction reduces cytokine-associated complications of transfusion.
Contributor Notes
Powered by PubFactory